- Home
- TRX vs ANIX Comparison
TRX vs ANIX Comparison
Compare TRX & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRX
- ANIX
- Stock Information
- Founded
- TRX 1990
- ANIX 1982
- Country
- TRX Canada
- ANIX United States
- Employees
- TRX N/A
- ANIX N/A
- Industry
- TRX
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- TRX
- ANIX Health Care
- Exchange
- TRX Nasdaq
- ANIX Nasdaq
- Market Cap
- TRX 81.1M
- ANIX 84.7M
- IPO Year
- TRX N/A
- ANIX 1987
- Fundamental
- Price
- TRX $0.33
- ANIX $2.79
- Analyst Decision
- TRX Strong Buy
- ANIX Strong Buy
- Analyst Count
- TRX 2
- ANIX 3
- Target Price
- TRX $1.63
- ANIX $9.00
- AVG Volume (30 Days)
- TRX 713.8K
- ANIX 54.9K
- Earning Date
- TRX 04-14-2025
- ANIX 06-03-2025
- Dividend Yield
- TRX N/A
- ANIX N/A
- EPS Growth
- TRX N/A
- ANIX N/A
- EPS
- TRX N/A
- ANIX N/A
- Revenue
- TRX $45,405,000.00
- ANIX N/A
- Revenue This Year
- TRX $68.64
- ANIX N/A
- Revenue Next Year
- TRX $22.37
- ANIX N/A
- P/E Ratio
- TRX N/A
- ANIX N/A
- Revenue Growth
- TRX 26.50
- ANIX N/A
- 52 Week Low
- TRX $0.27
- ANIX $2.07
- 52 Week High
- TRX $0.49
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- TRX 58.46
- ANIX 50.69
- Support Level
- TRX $0.32
- ANIX $2.60
- Resistance Level
- TRX $0.33
- ANIX $2.88
- Average True Range (ATR)
- TRX 0.02
- ANIX 0.20
- MACD
- TRX 0.00
- ANIX 0.02
- Stochastic Oscillator
- TRX 70.44
- ANIX 83.64
About TRX TRX Gold Corporation
TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. Its projects include the Buckreef project, and Itetemia Gold project whereas, its exploration stage project consists of the Lunguya project and the Luhala project.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.